drugset / Trial / NCT02868385

Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)

NCT02868385

RandomizedParallel-groupDouble-blindTreatment

Summary

An open label, randomized controlled trial of single vs. multiple treatments of praziquantel in intestinal African schistosomiasis in Côte d'Ivoire This study aims to determine the efficacy of repeated (up to four times) praziquantel treatment against S. mansoni infection in school-age children from Côte d'Ivoire using the traditional Kato-Katz thick smear technique, but also with more accurate and non-invasive antigen- and DNA-detection methods.

Timeline

Start
2018-10-01
Primary completion
2019-01-14
Completion
2019-01-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Praziquantel Small molecule 40 mg/kg Oral

Indications